Home > Healthcare > Medical Devices > Therapeutic Devices > Nephrostomy Devices Market

Nephrostomy Devices Market Size

  • Report ID: GMI4325
  • Published Date: May 2023
  • Report Format: PDF

Nephrostomy Devices Market Size

Nephrostomy Devices Market size was valued at around USD 1.1 billion in 2022 and is anticipated to grow at a CAGR of over 8.3% between 2023 and 2032.This incremental growth rate is owing to increasing prevalence of kidney disorders coupled with rising demand for minimally invasive surgeries.

 

Technological advancements pertaining to nephrostomy devices in the diagnosis and treatment of several chronic ailments including bladder, ovarian, and prostate cancers is expected to augment the market growth in the forecasted timeframe. Rising healthcare spending for providing better healthcare infrastructure, increasing disposable income and consistently increasing geriatric population are some of the major factors responsible for increased adoption of nephrostomy devices across the world.
 

A nephrostomy device is a medical device used to drain urine from the kidney through a tube that is inserted through the skin and into the kidney. These devices are intended to remove an obstruction in the urinary tract, such as a kidney stone or tumor, that is preventing urine from flowing properly.
 

However, availability of substitute procedures for nephrostomy can act as a significant barriers and thereby impede the nephrostomy devices market growth in the coming years. There are several alternative procedures that may be used instead of a nephrostomy, depending on the specific medical condition and individual circumstances of the patient. This procedure is majorly used to treat kidney stones, tumors, or other obstructions in the urinary tract.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for nephrostomy devices was worth around USD 1.1 billion in 2022 and is projected to surpass the valuation of around USD 2.4 billion by 2032 attributed to the high prevalence of kidney disorders, coupled with rising demand for minimally invasive surgeries.

The guidewires segment held over 32% revenue share and dominated the nephrostomy devices industry in 2022. Several benefits offered by guidewires in the management of kidney disorders are fueling product usage.

U.S. market for nephrostomy devices is projected to amass around USD 863 million by the end of 2032 driven by the presence of key market players and an increase in the number of chronic diseases.

Angiodynamics, Argon Medical Devices Inc, B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Medical, Envaste Ltd., Meditech, Devices Pvt. Ltd., Olympus Corporation, ROCAMED, Teleflex, Inc., and Uresil LLC., among others.

Nephrostomy Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 295
  • Countries covered: 30
  • Pages: 170
 Download Free Sample